Skip to main navigation
Our Science
Nucleos(t)ides
Pipeline & Programs
Hepatitis C
Bemnifosbuvir / Ruzasvir
About Hepatitis C
About Atea
About Us
Leadership
Careers
Contact
Investors
Overview
News & Events
News Releases
Events & Presentations
Publications
Financials
Annual Meeting
SEC Filings
Annual Reports
Quarterly Reports
Stock Info
Stock Quote & Chart
Historical Price Look up
Analyst Coverage
Corporate Governance
Documents & Charters
Management Team
Board of Directors
Committee Composition
Shareholder Resources
Investor FAQs
Email Alerts
Contact IR
RSS Feeds
Investor Relations
10-K
Breadcrumb
Investors
10-K
> Back to SEC
Go Back
SEC Filing Details
Form
10-K
Filing Date
February 28, 2023
Document Date
December 31, 2022
Form Description
Annual report which provides a comprehensive overview of the company for the past year
Filing Group
Annual Filings
Company
Atea Pharmaceuticals, Inc.
Issuer
Atea Pharmaceuticals, Inc.
Filing Formats
View HTML
Download PDF
Download DOC
Download XLS
XBRL
XBRL Viewer
EX-101.LAB - XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
EX-101.DEF - XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
EX-101.PRE - XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
EX-101.CAL - XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
XML - XBRL INSTANCE DOCUMENT
Investor FAQs
RSS Feeds
Email Alerts
Contact IR